Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Breast Cancer
100%
Radiation Therapy
79%
Mastectomy
25%
Neoplasm
24%
BRCA1
22%
Breathing
19%
Quadrantectomy
18%
Lung
17%
Magnetic Resonance Imaging
17%
Recurrent Disease
17%
Contralateral
17%
Intensity Modulated Radiation Therapy
14%
Local Therapy
13%
Morbidity
13%
Breast Reconstruction
13%
Cancer Therapy
13%
Continuous Positive Airway Pressure
12%
Accelerated Partial Breast Irradiation
12%
Cosmetics
12%
Lumpectomy
12%
Breast Radiotherapy
12%
Stereotactic Body Radiation Therapy
11%
Chemotherapy
11%
Cancer
10%
Airway Management
10%
Median Follow Up
10%
Arm
9%
Diseases
9%
Breast Tumor
9%
BRCA2
9%
Overall Survival
8%
Intraductal Carcinoma
8%
Cosmesis
8%
Oculopharyngeal Muscular Dystrophy
8%
Thoracic Wall
8%
Ptosis
8%
Quality of Life
8%
Mammography
7%
Treatment Planning
6%
Grafting
6%
Implant
6%
Tumor Recurrence
6%
Malignant Neoplasm
6%
Diplopia
6%
Progression Free Survival
6%
Radiation Dermatitis
6%
BRCA Mutation
5%
Tumor
5%
Body Mass Index
5%
Long-Term Outcome
5%
Keyphrases
Oncologists
36%
Cancer Patients
31%
Breast Cancer
30%
Breast Reconstruction
26%
Radiation Therapy
25%
Mental Health Distress
24%
BRCA2
21%
Partial Breast Irradiation
18%
Suicidality
16%
Breast Cancer Patients
16%
Breast
15%
Mastectomy
15%
Mutation Carriers
15%
Radiotherapy
15%
Cosmetic Outcome
14%
Tumor
13%
In Cancer
12%
Healthcare Professionals
12%
Contralateral Breast Cancer
9%
Suicide
9%
Social Workers
9%
Contralateral Breast
9%
Israel
9%
Breast Cancer Risk
8%
Patient Death
8%
Oncology nurses
8%
BRCA2 mutation
8%
Nurse Worker
8%
MRI-Linac
8%
Double-blind Trial
8%
Early Breast Cancer
7%
Grounded Theory Method
7%
Surgical Outcomes
7%
Whole Breast Radiotherapy
6%
Local Failure
6%
Local Control
6%
Overall Survival
6%
Risk-reducing Mastectomy
6%
Chemotherapy
6%
Autologous Breast Reconstruction
6%
Radiation Dermatitis
6%
Breast-conserving Treatment
6%
Suicide Risk
6%
Early Detection
6%
Oncology
6%
Single Institution
5%
Israeli
5%
Clinical Characteristics
5%
Local Treatment
5%
Multi-institutional
5%
